Benzotriazole1.0

Benzotriazole1.0 Struktur
92283-88-0
CAS-Nr.
92283-88-0
Englisch Name:
Benzotriazole1.0
Synonyma:
1.5;Benzotriazole1.0;2,3-Dianhydro-4,6-O-benzylidene-D-allitol;1,5:2,3-dianhydro-4,6-O-[(R)-phenylMethylene]-D-Allitol;D-Allitol, 1,5:2,3-dianhydro-4,6-O-[(R)-phenylmethylene]-;(1aS,3aR,6R,7aR,7bS)-6-Phenylhexahydrooxireno[2',3':4,5]pyrano[3,2-d][1,3]dioxine
CBNumber:
CB31025320
Summenformel:
C13H14O4
Molgewicht:
234.25
MOL-Datei:
92283-88-0.mol

Benzotriazole1.0 Eigenschaften

Siedepunkt:
369.1±37.0 °C(Predicted)
Dichte
1.262±0.06 g/cm3(Predicted)

Sicherheit

Benzotriazole1.0 Chemische Eigenschaften,Einsatz,Produktion Methoden

Benzotriazole1.0 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Benzotriazole1.0 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 11)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
NewCan Biotech Limited
+86-0571-86912261 +8613735419629
sales@newcanbio.com China 10026 58
Nextpeptide Inc
+86-0571-81612335 +8613336028439
sales@nextpeptide.com China 19915 58
Amadis Chemical Company Limited
571-89925085
sales@amadischem.com China 131981 58
Okeanos Tech Co,. Ltd. 010-62651721 18610486005
minghui.yu@okeanos.com.cn China 496 60
Creative Peptides
info@creative-peptides.com United States 6084 56
Shanghai Elestone Pharmaceutical Technology Co., Ltd. 021-36680027/1762825045
sales2@elestone.com.cn China 296 58
Aikon International Limited 025-58851090 13611564524
lwan@aikonchem.com China 15952 58
Chengdu MassCale Pharmaceutical Co., Ltd. 028-84552636 18084815636
chensfsc@126.com China 1448 58
PCL - Business, Laboratory Pharmaceutical 19150123681
Hu.xinyue@purechemland.com China 3567 58

  • 1.5
  • Benzotriazole1.0
  • 2,3-Dianhydro-4,6-O-benzylidene-D-allitol
  • 1,5:2,3-dianhydro-4,6-O-[(R)-phenylMethylene]-D-Allitol
  • (1aS,3aR,6R,7aR,7bS)-6-Phenylhexahydrooxireno[2',3':4,5]pyrano[3,2-d][1,3]dioxine
  • D-Allitol, 1,5:2,3-dianhydro-4,6-O-[(R)-phenylmethylene]-
  • 92283-88-0
Copyright 2019 © ChemicalBook. All rights reserved